110 related articles for article (PubMed ID: 21029027)
1. Treatment of diabetes with glucagon-like peptide-1 gene therapy.
Riedel MJ; Kieffer TJ
Expert Opin Biol Ther; 2010 Dec; 10(12):1681-92. PubMed ID: 21029027
[TBL] [Abstract][Full Text] [Related]
2. Engineered glucagon-like peptide-1-producing hepatocytes lower plasma glucose levels in mice.
Riedel MJ; Lee CW; Kieffer TJ
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E936-44. PubMed ID: 19190262
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.
Lee Y; Kwon MK; Kang ES; Park YM; Choi SH; Ahn CW; Kim KS; Park CW; Cha BS; Kim SW; Sung JK; Lee EJ; Lee HC
J Gene Med; 2008 Mar; 10(3):260-8. PubMed ID: 18085721
[TBL] [Abstract][Full Text] [Related]
4. The development of non-peptide glucagon-like peptide-1 receptor agonist for the treatment of type 2 diabetes.
Moon HS; Kim MK; Son MH
Arch Pharm Res; 2011 Jul; 34(7):1041-3. PubMed ID: 21811909
[TBL] [Abstract][Full Text] [Related]
5. DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes.
Riedel MJ; Gaddy DF; Asadi A; Robbins PD; Kieffer TJ
Gene Ther; 2010 Feb; 17(2):171-80. PubMed ID: 19865180
[TBL] [Abstract][Full Text] [Related]
6. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.
van Genugten RE; van Raalte DH; Diamant M
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S26-34. PubMed ID: 20115929
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 agonists and the development and growth of pancreatic beta-cells.
List JF; Habener JF
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E875-81. PubMed ID: 15140754
[TBL] [Abstract][Full Text] [Related]
8. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
Neumiller JJ
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidylpeptidase-4 (DPP-4) inhibitors are favourable to glucagon-like peptide-1 (GLP-1) receptor agonists: yes.
Scheen AJ
Eur J Intern Med; 2012 Mar; 23(2):126-31. PubMed ID: 22284241
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide 1 and its derivatives in the treatment of diabetes.
Nauck MA; Meier JJ
Regul Pept; 2005 Jun; 128(2):135-48. PubMed ID: 15780433
[TBL] [Abstract][Full Text] [Related]
11. The physiology of glucagon-like peptide 1.
Holst JJ
Physiol Rev; 2007 Oct; 87(4):1409-39. PubMed ID: 17928588
[TBL] [Abstract][Full Text] [Related]
12. The incretin system and its role in type 2 diabetes mellitus.
Holst JJ; Vilsbøll T; Deacon CF
Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
[TBL] [Abstract][Full Text] [Related]
13. The future of incretin-based therapy: novel avenues--novel targets.
Ahrén B
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():158-66. PubMed ID: 21824270
[TBL] [Abstract][Full Text] [Related]
14. GLP-1-mediated gene therapy approaches for diabetes treatment.
Tasyurek MH; Altunbas HA; Canatan H; Griffith TS; Sanlioglu S
Expert Rev Mol Med; 2014 Mar; 16():e7. PubMed ID: 24666581
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 for type 2 diabetes.
Ahrén B
Exp Cell Res; 2011 May; 317(9):1239-45. PubMed ID: 21237153
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide 1(GLP-1) in biology and pathology.
Meier JJ; Nauck MA
Diabetes Metab Res Rev; 2005; 21(2):91-117. PubMed ID: 15759282
[TBL] [Abstract][Full Text] [Related]
17. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice.
Kumar M; Hunag Y; Glinka Y; Prud'homme GJ; Wang Q
Gene Ther; 2007 Jan; 14(2):162-72. PubMed ID: 16943856
[TBL] [Abstract][Full Text] [Related]
19. New insights into the regulation of glucagon secretion by glucagon-like peptide-1.
Gromada J; Rorsman P
Horm Metab Res; 2004; 36(11-12):822-9. PubMed ID: 15655714
[TBL] [Abstract][Full Text] [Related]
20. Role of glucagon-like peptide-1 and its agonists on early prevention of cardiac remodeling in type 1 diabetic rat hearts.
Barakat GM; Nuwayri-Salti N; Kadi LN; Bitar KM; Al-Jaroudi WA; Bikhazi AB
Gen Physiol Biophys; 2011 Mar; 30(1):34-44. PubMed ID: 21460410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
